ANTI-TENASCIN-C (TNC) SINGLE-DOMAIN ANTIBODIES (NANOBODIES) AND USE THEREOF Application WO-2022175486-A1 World Intellectual Property Organisation (WIPO) 25 Aug 2022
ANTI-TENASCIN-C (TNC) SINGLE-DOMAIN ANTIBODIES (NANOBODIES) AND USE THEREOF Application EP-4047016-A1 European Patent Office 24 Aug 2022
Anti-ED-A immunoconjugates for inflammatory bowel disease Grant US-10239939-B2 United States of America 26 Mar 2019
Antigen associated with lung cancers and lymphomas Grant US-10202442-B2 United States of America 12 Feb 2019
Antigens associated with endometriosis, psoriatic arthritis and psoriasis Grant US-10112992-B2 United States of America 30 Oct 2018
Antigen associated with the neovasculature of tumour metastases Grant US-9896503-B2 United States of America 20 Feb 2018
Anti-ED-A immunoconjugates for inflammatory bowel disease Grant US-9695232-B2 United States of America 04 Jul 2017
Antigen associated with rheumatoid arthritis Grant US-9556257-B2 United States of America 31 Jan 2017
Antigens associated with endometriosis, psoriatic arthritis and psoriasis Grant US-9527907-B2 United States of America 27 Dec 2016
Antigen associated with the neovasculature of tumour metastases Grant US-9181347-B2 United States of America 10 Nov 2015
Antigen associated with the neovasculature of tumour metastases Grant US-8481684-B2 United States of America 09 Jul 2013
Antigen associated with the neovasculature of tumour metastases Grant US-8263041-B2 United States of America 11 Sep 2012
Antigen associated with rheumatoid arthritis Grant US-8222377-B2 United States of America 17 Jul 2012
(RADIO) LABELLED BIOTIN DERIVATIVES Application WO-1997010854-A1 World Intellectual Property Organisation (WIPO) 27 Mar 1997